Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy (Englisch)
- Neue Suche nach: Ottini, Laura
- Neue Suche nach: Silvestri, Valentina
- Neue Suche nach: Rizzolo, Piera
- Neue Suche nach: Falchetti, Mario
- Neue Suche nach: Zanna, Ines
- Neue Suche nach: Saieva, Calogero
- Neue Suche nach: Masala, Giovanna
- Neue Suche nach: Bianchi, Simonetta
- Neue Suche nach: Manoukian, Siranoush
- Neue Suche nach: Barile, Monica
- Neue Suche nach: Peterlongo, Paolo
- Neue Suche nach: Varesco, Liliana
- Neue Suche nach: Tommasi, Stefania
- Neue Suche nach: Russo, Antonio
- Neue Suche nach: Giannini, Giuseppe
- Neue Suche nach: Cortesi, Laura
- Neue Suche nach: Viel, Alessandra
- Neue Suche nach: Montagna, Marco
- Neue Suche nach: Radice, Paolo
- Neue Suche nach: Palli, Domenico
- Neue Suche nach: Ottini, Laura
- Neue Suche nach: Silvestri, Valentina
- Neue Suche nach: Rizzolo, Piera
- Neue Suche nach: Falchetti, Mario
- Neue Suche nach: Zanna, Ines
- Neue Suche nach: Saieva, Calogero
- Neue Suche nach: Masala, Giovanna
- Neue Suche nach: Bianchi, Simonetta
- Neue Suche nach: Manoukian, Siranoush
- Neue Suche nach: Barile, Monica
- Neue Suche nach: Peterlongo, Paolo
- Neue Suche nach: Varesco, Liliana
- Neue Suche nach: Tommasi, Stefania
- Neue Suche nach: Russo, Antonio
- Neue Suche nach: Giannini, Giuseppe
- Neue Suche nach: Cortesi, Laura
- Neue Suche nach: Viel, Alessandra
- Neue Suche nach: Montagna, Marco
- Neue Suche nach: Radice, Paolo
- Neue Suche nach: Palli, Domenico
In:
Breast Cancer Research and Treatment
;
134
, 1
; 411-418
;
2012
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy
-
Beteiligte:Ottini, Laura ( Autor:in ) / Silvestri, Valentina ( Autor:in ) / Rizzolo, Piera ( Autor:in ) / Falchetti, Mario ( Autor:in ) / Zanna, Ines ( Autor:in ) / Saieva, Calogero ( Autor:in ) / Masala, Giovanna ( Autor:in ) / Bianchi, Simonetta ( Autor:in ) / Manoukian, Siranoush ( Autor:in ) / Barile, Monica ( Autor:in )
-
Erschienen in:Breast Cancer Research and Treatment ; 134, 1 ; 411-418
-
Verlag:
- Neue Suche nach: Springer US
- Neue Suche nach: Springer Science + Business Media B.V.
-
Erscheinungsort:Dordrecht [u.a.]
-
Erscheinungsdatum:2012
-
ISSN:
-
ZDBID:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
- Neue Suche nach: 44.92$jGynäkologie / 44.92
- Weitere Informationen zu Basisklassifikation
-
Schlagwörter:
-
Klassifikation:
BKL: 44.92$jGynäkologie / 44.92 Gynäkologie -
Datenquelle:
Inhaltsverzeichnis – Band 134, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Early diagnostic protein biomarkers for breast cancer: how far have we come?Opstal-van Winden, Annemieke W. J. / Vermeulen, Roel C. H. / Peeters, Petra H. M. / Beijnen, Jos H. / van Gils, Carla H. et al. | 2011
- 13
-
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancerRugo, Hope S. / Jo Chien, A. / Franco, Sandra X. / Stopeck, Alison T. / Glencer, Alexa / Lahiri, Soumi / Arbushites, Michael C. / Scott, Janet / Park, John W. / Hudis, Clifford et al. | 2011
- 21
-
Molecular insights on basal-like breast cancerValentin, Mev Dominguez / da Silva, Sabrina Daniela / Privat, Maud / Alaoui-Jamali, Moulay / Bignon, Yves-Jean et al. | 2012
- 31
-
Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer modelMousseau, Yoanne / Mollard, Séverine / Faucher-Durand, Karine / Richard, Laurence / Nizou, Angélique / Cook-Moreau, Jeanne / Baaj, Yasser / Qiu, Hao / Plainard, Xavier / Fourcade, Laurent et al. | 2011
- 41
-
Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathwayTanic, Miljana / Zajac, Magdalena / Gómez-López, Gonzalo / Benítez, Javier / Martínez-Delgado, Beatriz et al. | 2011
- 53
-
A monoclonal antibody to the human HER3 receptor inhibits Neuregulin 1-beta binding and co-operates with Herceptin in inhibiting the growth of breast cancer derived cell linesBlackburn, Edith / Zona, Stefania / Murphy, Mariana L. / Brown, Ian R. / Chan, Samuel K. W. / Gullick, William J. et al. | 2011
- 61
-
T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumorsWang, Li-Xin / Plautz, Gregory E. et al. | 2011
- 71
-
Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferationShubbar, Emman / Vegfors, Jenny / Carlström, Maria / Petersson, Stina / Enerbäck, Charlotta et al. | 2011
- 81
-
Biologically effective dose and breast cancer conservative treatment: is duration of radiation therapy really important?Sanpaolo, Pietro / Barbieri, Viviana / Genovesi, Domenico / Fusco, Vincenzo / Ausili Cèfaro, Giampiero et al. | 2011
- 89
-
Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancerInao, Touko / Harashima, Nanae / Monma, Hiroyuki / Okano, Shinji / Itakura, Masayuki / Tanaka, Tsuneo / Tajima, Yoshitsugu / Harada, Mamoru et al. | 2011
- 101
-
SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE)Wang, Chunyu / Uray, Ivan P. / Mazumdar, Abhijit / Mayer, Julie Ann / Brown, Powel H. et al. | 2012
- 117
-
Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicinAbu Ajaj, Khalid / Graeser, Ralph / Kratz, Felix et al. | 2012
- 131
-
Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patientsFumagalli, Caterina / Pruneri, Giancarlo / Possanzini, Paola / Manzotti, Michela / Barile, Monica / Feroce, Irene / Colleoni, Marco / Bonanni, Bernardo / Maisonneuve, Patrick / Radice, Paolo et al. | 2012
- 139
-
Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cellsKajitani, Keiko / Tanaka, Yuka / Arihiro, Koji / Kataoka, Tsuyoshi / Ohdan, Hideki et al. | 2012
- 157
-
Stromal–epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancerXu, Cong / Langenheim, John F. / Chen, Wen Y. et al. | 2012
- 171
-
Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patientsZhao, Xiangshan / Mirza, Sameer / Alshareeda, Alaa / Zhang, Ying / Gurumurthy, Channabasavaiah Basavaraju / Bele, Aditya / Kim, Jun Hyun / Mohibi, Shakur / Goswami, Monica / Lele, Subodh M. et al. | 2012
- 181
-
Autologous microsurgical breast reconstruction and coronary artery bypass grafting: an anatomical study and clinical implicationsRozen, Warren M. / Ye, Xuan / Guio-Aguilar, Pedro L. / Alonso-Burgos, Alberto / Goldblatt, John / Ashton, Mark W. / Whitaker, Iain S. et al. | 2012
- 199
-
Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapyGirgert, Rainer / Emons, Günter / Gründker, Carsten et al. | 2012
- 207
-
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancerGravgaard, Karina H. / Lyng, Maria B. / Laenkholm, Anne-Vibeke / Søkilde, Rolf / Nielsen, Boye Schnack / Litman, Thomas / Ditzel, Henrik J. et al. | 2012
- 219
-
MUTYH gene variants and breast cancer in a Dutch case–control studyOut, Astrid A. / Wasielewski, Marijke / Huijts, Petra E. A. / van Minderhout, Ivonne J. H. M. / Houwing-Duistermaat, Jeanine J. / Tops, Carli M. J. / Nielsen, Maartje / Seynaeve, Caroline / Wijnen, Juul T. / Breuning, Martijn H. et al. | 2012
- 229
-
14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancersNakamura, Yukiko / Oshima, Kazuteru / Naoi, Yasuto / Nakayama, Takahiro / Kim, Seung Jin / Shimazu, Kenzo / Shimomura, Atsushi / Maruyama, Naomi / Tamaki, Yasuhiro / Noguchi, Shinzaburo et al. | 2012
- 237
-
Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancerSchoppmann, Sebastian F. / Berghoff, Anna / Dinhof, Carina / Jakesz, Raimund / Gnant, Michael / Dubsky, Peter / Jesch, Bettina / Heinzl, Harald / Birner, Peter et al. | 2012
- 245
-
Aromatase inhibitors and calcium absorption in early stage breast cancerTevaarwerk, Amye / Burkard, Mark E. / Wisinski, Kari B. / Shafer, Martin M. / Davis, Lisa A. / Gogineni, Jyothi / Crone, Elizabeth / Hansen, Karen E. et al. | 2012
- 253
-
An abnormal screening mammogram causes more anxiety than a palpable lump in benign breast diseaseKeyzer-Dekker, C. M. G. / van Esch, L. / de Vries, J. / Ernst, M. F. / Nieuwenhuijzen, G. A. P. / Roukema, J. A. / van der Steeg, A. F. W. et al. | 2012
- 259
-
The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?Massabeau, Carole / Sigal-Zafrani, Brigitte / Belin, Lisa / Savignoni, Alexia / Richardson, Marion / Kirova, Youlia M. / Cohen-Jonathan-Moyal, Elizabeth / Mégnin-Chanet, Frédérique / Hall, Janet / Fourquet, Alain et al. | 2012
- 267
-
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyvan Nes, J. G. H. / Fontein, D. B. Y. / Hille, E. T. M. / Voskuil, D. W. / van Leeuwen, F. E. / de Haes, J. C. J. M. / Putter, H. / Seynaeve, C. / Nortier, J. W. R. / van de Velde, C. J. H. et al. | 2012
- 277
-
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancerMunzone, Elisabetta / Botteri, E. / Sciandivasci, A. / Curigliano, G. / Nolè, F. / Mastropasqua, M. / Rotmensz, N. / Colleoni, M. / Esposito, A. / Adamoli, L. et al. | 2012
- 283
-
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept studyPestrin, Marta / Bessi, Silvia / Puglisi, Fabio / Minisini, Alessandro M. / Masci, Giovanna / Battelli, Nicola / Ravaioli, Alberto / Gianni, Lorenzo / Di Marsico, Roberta / Tondini, Carlo et al. | 2012
- 291
-
High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot studyOnitilo, Adedayo A. / Engel, Jessica M. / Stankowski, Rachel V. / Liang, Hong / Berg, Richard L. / Doi, Suhail A. R. et al. | 2012
- 299
-
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifenePowles, Trevor J. / Diem, Susan J. / Fabian, Carol J. / Neven, Patrick / Wickerham, D. Lawrence / Cox, David A. / Muram, David / Agnusdei, Donato / Dowsett, Sherie A. / Amewou-Atisso, Messan et al. | 2012
- 307
-
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancerYu, Ke-Da / Zhou, Ying / Liu, Guang-Yu / Li, Bin / He, Ping-Qing / Zhang, Hong-Wei / Lou, Li-Hua / Wang, Xiao-Jia / Wang, Shui / Tang, Jin-Hai et al. | 2012
- 315
-
Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgeryLevy, Ellen W. / Pfalzer, Lucinda A. / Danoff, Jerome / Springer, Barbara A. / McGarvey, Charles / Shieh, Ching-yi / Morehead-Gee, Alicia / Gerber, Lynn H. / Stout, Nicole L. et al. | 2012
- 325
-
Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicityToulmonde, M. / Madranges, N. / Brouste, V. / Donamaria, C. / MacGrogan, G. / Durand, M. / Bonnefoi, H. / Mauriac, L. / Debled, M. et al. | 2012
- 333
-
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancersSantarpia, Libero / Qi, Yuan / Stemke-Hale, Katherine / Wang, Bailiang / Young, Elliana J. / Booser, Daniel J. / Holmes, Frankie A. / O’Shaughnessy, Joyce / Hellerstedt, Beth / Pippen, John et al. | 2012
- 345
-
A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)Li, Tianhong / Guo, Mengye / Gradishar, William J. / Sparano, Joseph A. / Perez, Edith A. / Wang, Molin / Sledge, George W. et al. | 2012
- 353
-
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group StudyFostira, Florentia / Tsitlaidou, Marianthi / Papadimitriou, Christos / Pertesi, Maroulio / Timotheadou, Eleni / Stavropoulou, Alexandra V. / Glentis, Stavros / Bournakis, Evangelos / Bobos, Mattheos / Pectasides, Dimitrios et al. | 2012
- 363
-
Breast cancer incidence trends in European women aged 20–39 years at diagnosisMerlo, D. F. / Ceppi, M. / Filiberti, R. / Bocchini, V. / Znaor, A. / Gamulin, M. / Primic-Žakelj, M. / Bruzzi, P. / Bouchardy, C. / Fucic, A. et al. | 2012
- 371
-
Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancerKamal, A. H. / Camacho, F. / Anderson, R. / Wei, W. / Balkrishnan, R. / Kimmick, G. et al. | 2012
- 379
-
Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controlsJeffe, D. B. / Pérez, M. / Liu, Y. / Collins, K. K. / Aft, R. L. / Schootman, M. et al. | 2012
- 393
-
Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survivalShen, Jing / Gammon, Marilie D. / Terry, Mary Beth / Bradshaw, Patrick T. / Wang, Qiao / Teitelbaum, Susan L. / Neugut, Alfred I. / Santella, Regina M. et al. | 2012
- 401
-
CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxelHertz, Daniel L. / Motsinger-Reif, Alison A. / Drobish, Amy / Winham, Stacey J. / McLeod, Howard L. / Carey, Lisa A. / Dees, E. Claire et al. | 2012
- 411
-
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in ItalyOttini, Laura / Silvestri, Valentina / Rizzolo, Piera / Falchetti, Mario / Zanna, Ines / Saieva, Calogero / Masala, Giovanna / Bianchi, Simonetta / Manoukian, Siranoush / Barile, Monica et al. | 2012
- 419
-
Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL)Neugut, Alfred I. / Hillyer, Grace Clarke / Kushi, Lawrence H. / Lamerato, Lois / Leoce, Nicole / Nathanson, S. David / Ambrosone, Christine B. / Bovbjerg, Dana H. / Mandelblatt, Jeanne S. / Magai, Carol et al. | 2012
- 429
-
Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancerSnape, Katie / Ruark, Elise / Tarpey, Patrick / Renwick, Anthony / Turnbull, Clare / Seal, Sheila / Murray, Anne / Hanks, Sandra / Douglas, Jenny / Stratton, Michael R. et al. | 2012
- 435
-
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeatCortesi, Laura / De Nicolo, Arcangela / Medici, Veronica / Marino, Marco / Turchetti, Daniela / Pradella, Laura Maria / Rossi, Giulio / Parisini, Emilio / Federico, Massimo et al. | 2012
- 443
-
Comments on the use of a single or multiple probeset approach for microarray-based analyses of routine molecular markers in breast cancerSpyratos, Frédérique / Valet, Fabien / Bièche, Ivan / Scott, Véronique / Lehmann-Che, Jacqueline / Asselain, Bernard / Tembo, Olivier / Marty, Michel / de Cremoux, Patricia et al. | 2012
- 449
-
Erratum to: Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agentsKadra, Gais / Finetti, Pascal / Toiron, Yves / Viens, Patrice / Birnbaum, Daniel / Borg, Jean-Paul / Bertucci, François / Gonçalves, Anthony et al. | 2012